Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Lamers

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
ACS Chemical Biology|April 30, 2010
Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237Dominic A Sloane, Michael Z Trikic, Matthew L H Chu, et al.
Plos One|May 13, 2014
Quantification assays for total and polyglutamine-expanded huntingtin proteinsDouglas Macdonald, Michela A Tessari, Ivette Boogaard, et al.
Journal of Medicinal Chemistry|October 27, 2020
[1,2,4]Triazolo[1,5-<i>a</i>]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided ExplorationGary Tresadern, Ingrid Velter, Andrés A Trabanco, et al.
Plos One|April 8, 2022
Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validationDavid F Fischer, Sipke Dijkstra, Kimberly Lo, et al.
Iscience|June 9, 2025
Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humansEmil Colstrup, Rie Nakajima, Jelte M M Krol, et al.
Frontiers in Immunology|May 3, 2021
Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic ReviewOlivia A C Lamers, Bas M Smits, Helen Louisa Leavis, et al.
Nature Communications|June 12, 2026
Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trialA D O Hensen, C Harmanus, P H Verbeek-Menken, et al.
The Lancet. Infectious Diseases|July 6, 2023
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the NetherlandsJohan L van der Plas, Vincent P Kuiper, Wilhelmina M Bagchus, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2024
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster doseGeert V T Roozen, Manon L M Prins, Corine Prins, et al.
The New England Journal of Medicine|November 20, 2024
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria ParasiteOlivia A C Lamers, Blandine M D Franke-Fayard, Jan Pieter R Koopman, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
ACS Chemical Biology|April 30, 2010
Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237Dominic A Sloane, Michael Z Trikic, Matthew L H Chu, et al.
Plos One|May 13, 2014
Quantification assays for total and polyglutamine-expanded huntingtin proteinsDouglas Macdonald, Michela A Tessari, Ivette Boogaard, et al.
Journal of Medicinal Chemistry|October 27, 2020
[1,2,4]Triazolo[1,5-<i>a</i>]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided ExplorationGary Tresadern, Ingrid Velter, Andrés A Trabanco, et al.
Plos One|April 8, 2022
Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validationDavid F Fischer, Sipke Dijkstra, Kimberly Lo, et al.
Iscience|June 9, 2025
Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humansEmil Colstrup, Rie Nakajima, Jelte M M Krol, et al.
Frontiers in Immunology|May 3, 2021
Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic ReviewOlivia A C Lamers, Bas M Smits, Helen Louisa Leavis, et al.
Nature Communications|June 12, 2026
Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trialA D O Hensen, C Harmanus, P H Verbeek-Menken, et al.
The Lancet. Infectious Diseases|July 6, 2023
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the NetherlandsJohan L van der Plas, Vincent P Kuiper, Wilhelmina M Bagchus, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 29, 2024
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster doseGeert V T Roozen, Manon L M Prins, Corine Prins, et al.
The New England Journal of Medicine|November 20, 2024
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria ParasiteOlivia A C Lamers, Blandine M D Franke-Fayard, Jan Pieter R Koopman, et al.
Pageof 3